Skip to main content
GoodwinGoodwin
Events

Second Annual AI & Drug Discovery Symposium: Revolutionizing the Future of Medicine

Thursday, October 1, 2026 | 1:00 - 6:30 PM ET
Goodwin, 100 Northern Avenue, Boston, Massachusetts, 02210
View PDF

Summary

Goodwin is hosting our Second Annual AI & Drug Discovery Symposium at our Boston office on October 1. This event will bring together leaders across life sciences, technology, and investment to discuss the opportunities and challenges shaping the next generation of AI-enabled drug discovery. Through engaging conversations and expert insights, we'll explore emerging market and investment dynamics, innovative collaboration models, regulatory and policy considerations, and approaches to creating, protecting, and maximizing value across proprietary data, intellectual property, and AI-enabled platforms in an evolving life sciences landscape.

Agenda

Time (ET) Details
Registration

Opening Remarks

Fireside Chat: Market and Investment Trends in AI and Life Sciences

Intellectual Property Strategy in the Age of AI: Strategize Now to Win Later
Networking Break

Regulatory, Governance, and Policy Perspectives

  • Elizabeth Mulkey, Partner, Goodwin
  • Andrew Barnhill, JD, Senior Vice President, BIO
  • Hal Stowe, Director, Regulatory Affairs, Eurofins North America
  • Peter Meyer, PhD, Managing Director, Outcome Capital

Deal Translation: Structuring AI Partnership Models in Drug Discovery

  • Erini Svokos, Partner, Goodwin
  • Bethany Withers, Partner, Goodwin
  • Surge Biswas, CEO, Nabla Bio
  • Hilary Eaton, Ph.D., Head of Transactions and M&A, Genetic Medicine and AI, Lilly

Fireside Chat: AI Governance and Security

  • Kaitlin Betancourt, Partner, Goodwin
  • WeiQing Zhou, Co-Founder and Chief Operating Officer, LifeMine Therapeutics

Closing Remarks
Networking Reception

Ahead of the symposium, we invite you to explore our latest article, “Proprietary Data and Specialist AI: The Evolving Market in Life Sciences Transactions,” for additional perspectives on the opportunities and challenges facing the sector.

The program will conclude with a networking reception, offering attendees the opportunity to connect with fellow executives, investors, advisors, and innovators across the life sciences and technology ecosystems over drinks and light refreshments.

Register

Speakers

Related Content

See More